Basics |
Forte Biosciences, Inc.
|
IPO Date: |
April 10, 2017 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$48.31M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.50 | 3.97%
|
Avg Daily Range (30 D): |
$0.54 | 7.96%
|
Avg Daily Range (90 D): |
$0.79 | 6.45%
|
Institutional Daily Volume |
Avg Daily Volume: |
.22M |
Avg Daily Volume (30 D): |
.03M |
Avg Daily Volume (90 D): |
.03M |
Trade Size |
Avg Trade Size (Sh.): |
172 |
Avg Trade Size (Sh.) (30 D): |
85 |
Avg Trade Size (Sh.) (90 D): |
63 |
Institutional Trades |
Total Inst.Trades: |
75 |
Avg Inst. Trade: |
$1.82M |
Avg Inst. Trade (30 D): |
$.67M |
Avg Inst. Trade (90 D): |
$.67M |
Avg Inst. Trade Volume: |
.01M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.89M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
8.46K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-12.17
|
$3.18
|
$-12.17
|
Diluted EPS
|
$-12.17
|
$3.18
|
$-12.17
|
Revenue
|
$ 1.31M
|
$ 1.31M
|
$ 1.31M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -35.48M
|
$ -7.16M
|
$ -35.48M
|
Operating Income / Loss
|
$ -36.6M
|
$ -7.35M
|
$ -36.6M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -14.88M
|
$ 5.88M
|
$ -14.88M
|
PE Ratio
|
|
|
|
Splits |
Aug 28, 2024:
25:1
|
|